Announced
Completed
Temasek completed the $85m investment in Molbio Diagnostics.
Synopsis
Temasek, a Singapore-based investment firm, completed the $85m investment in Molbio Diagnostics, a healthcare solutions provider. "These funds from the minority stake investment will be used for domestic and external business development, overseas market expansion, and research and development," Sriram Natarajan, Molbio Diagnostics Director and CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite